Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGO2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | ARG2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | EIF4EBP2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | DDX51 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | KBTBD6 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | APOC4-APOC2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | AHCYL2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | ZNF285 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ALLC | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |